Yesterday, the Centers for Medicare & Medicaid Services (CMS) shared their plans for federal payments to Medicare Advantage plans, and Humana (HUM) has taken a hit on the news. The stock is down 15% so far Tuesday morning. CMS first disclosed these plans back in January. At the time, Humana warned that should the [...]
Shares of Walgreens Boots Alliance (WBA) are relatively flat this morning after the company reported second-quarter earnings that have analysts and investors alike concerned about profits and the long-term viability of the company’s business model. Last quarter, we wrote about Walgreens cutting their quarterly dividend and the fallout that ensued - including removal from [...]
Merck (MRK) received US FDA approval on Tuesday after the market’s close for Winrevair to treat pulmonary arterial hypertension (PAH), causing the stock to climb 4.6% pre-market. The company’s market cap is around $332.7 billion, indicating any notable movement is a result of a significant event, so the approval demonstrates a pretty big win [...]
Humana Inc. (HUM) is down more than 14% in Thursday’s trading session, as the losses keep piling up for investors over the past few weeks. The managed care company cut its guidance for 2024 while we’re not even out of January yet. Sky-high medical costs are taking a toll on the company, which has [...]
Johnson & Johnson (JNJ) is known for baby products and the single-shot COVID-19 vaccine, making it a significant booster if you invested before the pandemic. However, following recent lawsuits, JNJ settled to pay $700 million following an investigation over its baby powder, while the COVID-19 vaccine was discontinued in the US, leading to an [...]
Shares of Cardinal Health (CAH) fell more than 3% in Tuesday’s trading session despite the company announcing that it expects its full-year fiscal 2024 earnings to come in at the high range of its guidance. The outlook in question is somewhere between $6.75 to $7 a share. Meanwhile, the FactSet consensus is $6.96. This [...]
Shares of Walgreens (WBA) are down more than 6% in Thursday’s trading session after the drugstore retailer reported its fiscal first-quarter earnings. Earnings per share of 66 cents beat the consensus of 61 cents, while revenue of $36.71 billion topped the $34.86 billion expected. The company did report a net loss for the quarter [...]
Shares of Moderna (MRNA) climbed 13% in yesterday’s trading session after being upgraded to a buy at Oppenheimer. The stock fell a bit in Wednesday’s trading session, but has since settled at around even on the day. Hartaj Singh and a team of analysts see dramatic upside potential over the next few years for [...]
Pfizer (PFE) fell 9% in Wednesday morning trading after the company’s weak forecast for 2024 left much to be desired in the eyes of investors and analysts alike. The stock is headed toward a 10-year low, and has now shed 50% of its value in the last year alone. The drugmaker has been steadily [...]
By Leslie N. Masonson, MBA Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH), is a bio-pharmaceutical firm, that develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products to its customers in the United States, China, and France. The company was incorporated in 1996 in Rancho Cucamonga, California where it is currently headquartered. It has [...]
